<DOC>
	<DOCNO>NCT00518453</DOCNO>
	<brief_summary>Due antigenic change influenza virus , virus strain use influenza vaccine adjust every year accord WHO CPMP recommendation . Immunogenicity tolerability newly compose vaccine subject evaluation yearly clinical trial non-elderly adult elderly subject ( CPMP/BWP/214/96 ) .</brief_summary>
	<brief_title>Immunogenicity Surface Antigen , Inactivated Influenza Vaccine Formulation 2007-2008</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy Subjects eligible enrollment study male female adult volunteer Any serious disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Influenza vaccine</keyword>
</DOC>